Title : Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.

Pub. Date : 2017 May 17

PMID : 28338324






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101. lorcaserin 5-hydroxytryptamine receptor 2C Rattus norvegicus
2 Lorcaserin (LOR) is a selective 5-HT2C receptor agonist that has been FDA approved as a treatment for obesity. lorcaserin 5-hydroxytryptamine receptor 2C Rattus norvegicus
3 Lorcaserin (LOR) is a selective 5-HT2C receptor agonist that has been FDA approved as a treatment for obesity. lorcaserin 5-hydroxytryptamine receptor 2C Rattus norvegicus